郑 虹 丁 凤 魏苗苗 张 旸 黄晓东 高志娟 陈国华

广东省惠州市第一人民医院(516000)

·临床分析·

郑 虹 丁 凤 魏苗苗 张 旸 黄晓东 高志娟 陈国华

广东省惠州市第一人民医院(516000)

1 材料与方法

1.1一般资料

1.2数据获取及干预方法

1.3仪器与试剂

LH、FSH、E2测定采用美国 Abbott 公司的 I-2000 发光免疫分析仪及配套试剂，严格按照说明书进行操作。超声诊断采用美国 Voluson E8彩超仪、日本东芝NemioMX超声诊断仪。

1.4统计学分析

2 结果

2.1各组对象治疗前后临床指证测定比较

表1 各组研究对象治疗前后临床指证比较

*与对照组比较P<0.05

2.2各组对象治疗前后血中性激素比较

2.3各组对象治疗前后性腺发育变化比较

表2 各组研究对象治疗前后血清生殖激素水平比较

*与对照组比较P<0.05

表3 各组研究对象治疗前后性腺发育情况比较

*与对照组比较P<0.05

3 讨论

3.1重型地贫的相关研究状况

3.2目前重型地贫的治疗方法

3.3本研究结果发现

[1] Muncie HL Jr,Campbell J.Alpha and beta thalassemia[J].Am FamPhysician, 2009, 80(4):339-344.

[2] De Sanctis V, A.Eleftheriou, C.Malaventura.Prevalence of endocrine complications and short stature in patients with thalassaemia major: a multicenter study by the Thalassaemia International Federation (TIF) [J].Pediatr Endocrinol Rev, 2004, 2 Suppl 2:249-255.

[3] Moayeri H., Z.Oloomi.Prevalence of growth and puberty failure with respect to growth hormone and gonadotropins secretion in beta-thalassemia major [J].Arch Iran Med, 2006, 9(4):329-334.

[4] 陆时运, 周仲昊, 王晨, 等.去铁胺治疗长期输血所致铁过载的疗效观察[J].隋床医药实践, 2011, 20 (2):110-112.

[5] Belhoul,Bakir ML,et al.Prevalence of iron overload complications among patients with b-thalassemia major treated at Dubai Thalassemia Centre[J].Ann Saudi Med.2013, 33(1):18-21.

[6] Yin XL，Wu ZK, He YY,et al.Treatment and complications of thalassemia major in Gangxi，Southern China[J].Pediatr Blood Cancer 2011,57(7):1174-1178.

[8] 王燕燕, 李晓辉, 徐西华.地中海贫血诊治进展与我国现状[J].中国实用儿科杂志，2013, 28 (6) : 473-476.

[9] Al-Rimawi HS,Jallad MF,Amarin ZO,et al.Hypoth alamic-pituitarygonadal function in adolescent females with beta-thalassemia major [J].Int JGyneco bstet,2005, 1(90):44-47.

[10] Karamifarh, Shahriarim, Et A.L Amirhakimigh.Failure of puberty and linear growth in beta- thalassemia major[J].Turk Haematol, 2005, 22(2):65-69.

[11] Borgna-Pignatri C, Rugoloeto S, De StefanoP, et al.Survival and complications in patients with beta-thalassaemia major treated with transfusin and deferoxamine.Haematologila, 2004,89(10):1187-1193.

[12] 张新华, 黄有文.血液病诊断及疗效标准//张之南，沈梯，主编.血液病诊断与疗效标准.3版.北京:科学技术出版社，2007:29-34.

[13] De Sanctis V.Growth and puberty and its management in thalassaemiac[J].Horm Res,2007,58(Suppl 1):72-79.

[14] Heshmat Moayeri,Zohreh Oloomi.Prevalence of Growth and Puberty Failure with Respect to Growth Hormone and Gonadotropins Secretion in Beta-Thalassemia Major[J].Arch Iran Med,2006,9(4):331-333.

[15] C Roth A, Pekrun M, Bartz H, et al.Short stature and failure of pubertal development in thalassasemia major: evidence for hypothalamic neurosecretory dysfunction of growth hormone secretion and defective pituitary gonadotropin secretion[J].Eur J Pediatr,1997,156:778-781.

[16] 李辉, 季成, 叶宗南, 等.2009年中国0-18岁儿童身高、体重的标准化生长曲线.中华儿科杂志[J] .2009, 47 (7):487-492.

[17] Pan HF, Long GF, Li Q, et al.Current status ofthalassemia in minority populations in Gangxi, China[J].Clin Genet,2007,71 (5):419-426.

[20] Shander A, Sazam a K.C finical consequences of iron overload from chronic red blood cell transfusions,its diagnosis,and its management by chelation therapy.Transfusion, 2010, 50(5): 1144-1155.

[21] Taksande A,Prabhu S,Venkatesh S.Cardiovascular aspect of Beta thalassemia.Cardiovasc Hematol Agents Med Chem[J].2012 Mar 1;10(1):25-30.

[22] Thalassemia.International Federation:Guidelines for the clinical management of thalassemia 2nd edition.2010.

[24] 吴学东, 井远方, 温建芸, 等.造血干细胞移植治疗地中海贫血[J].中国组织工程研究，2012, 6 (23):4339 -4348.

[25] Angelucci E .Hematopoietic stem cell transplantation in thalassemia[J] .Hematology Am Soc Hematol Educ Program, 2010, 456 -462.

[26] Schrier SL, Angehicei E .New strategies in the treatment of the thalassemias [J].Annu Rev Med, 2005，56: 157-171.

[责任编辑：董 琳]

ZHENG Hong, DING Feng, WEI Miaomiao, ZHANG Yang, HUANG Xiaodong, GAO Zhijuan, CHEN Guohua

TheFirstpeople’sHospitalofHuizhou,Guangdong, 516000

10.3969/j.issn.1004-8189.2017.06.007

广东省惠州市科技计划项目(2014Y042)

2017-01-00

2017-03-15